Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mallinckrodt Plc (NYSE:MNK)

46.38
Delayed Data
As of 4:02pm ET
 +0.19 / +0.41%
Today’s Change
41.57
Today|||52-Week Range
85.83
-6.90%
Year-to-Date

Today’s Trading

Previous close46.19
Today’s open46.25
Day’s range45.75 - 46.60
Volume806,345
Average volume (3 months)2,007,428
Market cap$4.8B
Dividend yield--
Data as of 4:02pm ET, 04/27/2017

Growth & Valuation

Earnings growth (last year)+78.72%
Earnings growth (this year)--
Earnings growth (next 5 years)+6.00%
Revenue growth (last year)+1.01%
P/E ratio25.3
Price/Sales2.30
Price/Book0.94

Competitors

 Today’s
change
Today’s
% change
TAROTaro Pharmaceutical ...-1.40-1.19%
ALNYAlnylam Pharmaceutic...-1.25-2.31%
OPKOPKO Health Inc0.000.00%
AGNPRAAllergan plc+10.36+1.22%
Data as of 4:02pm ET, 04/27/2017

Financials

Next reporting dateMay 8, 2017
EPS forecast (this quarter)$1.64
Annual revenue (last year)$3.4B
Annual profit (last year)$548.0M
Net profit margin14.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Mark C. Trudeau
Senior Vice President-
Global Operations
Frank Scholz
Corporate headquarters
Chesterfield, Derbyshire

Forecasts